المؤلفون: Ciria-Suarez L, Calderon C, Montes AF, Antoñanzas M, Hernández R, Rogado J, Pacheco-Barcia V, Asensio-Martínez E, Palacín-Lois M, Jimenez-Fonseca P

المصدر: SUPPORTIVE CARE IN CANCER
r-FISABIO. Repositorio Institucional de Producción Científica
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::48c6c235421abceb2a4609a2eb65d0be
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11903

المؤلفون: Montes, AF, Lopez, CL, Martinez, GA, Lopez, DP, Munoz, AML, Paredes, BG, Abad, DG, Lopez, CC, Fonseca, PJ, Plazas, JG, Doldan, MCL, de Castro, EM, Canovas, MS, Puyal, MT, Ayala, BL, Martel, IJ, Flores, ML, Carmona-Bayonas, A

المصدر: ONCOLOGIST
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: Survival, Antiangiogenic, Aflibercept, Prognosis, Colorectal cancer, Real-world data, Nomogram

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f0078608c3c4b9e12d13289b6915f17e
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2861

المؤلفون: Andres J. Muñoz Martín, R. Pazo-Cid, Jaime Feliu, R. Vera, A. F. Montes, Rocio Garcia-Carbonero, Juan Maurel, T. M. Mercadé, Alfredo Carrato, Mª A. Gómez-España

المساهمون: Institut Català de la Salut, [Gómez-España MA] Medical Oncology Department, Hospital Universitario Reina Sofía, IMIBIC, CIBERONC, Córdoba, Spain. [Montes AF] Medical Oncology Department, Complexo Hospitalario Universitario de Ourense (CHUO), Orense, Spain. [Garcia-Carbonero R] Medical Oncology Department, Hospital Universitario, UCM, CNIO, CIBERONC, 12 de Octubre, IIS imas12, Madrid, Spain. [Macarulla Mercadé T] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Maurel J] Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain. [Martín AM] Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Scientia
Clinical & Translational Oncology
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza

مصطلحات موضوعية: Oncology, Cancer Research, FOLFIRINOX, medicine.medical_treatment, Tracte biliar - Càncer - Tractament - Espanya, Leucovorin, Medical Oncology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, 030212 general & internal medicine, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias del tracto biliar [ENFERMEDADES], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Societies, Medical, terapéutica [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Standard treatment, Palliative Care, General Medicine, Chemoradiotherapy, Neoadjuvant Therapy, Oxaliplatin, Geographic Locations::Europe::Spain [GEOGRAPHICALS], Biliary Tract Neoplasms, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Fluorouracil, Adjuvant, medicine.drug, medicine.medical_specialty, Paclitaxel, Clinical Guides in Oncology, Irinotecan, Capecitabine, 03 medical and health sciences, Pancreatic cancer, Internal medicine, Albumins, Chemotherapy, Humans, Neoplasm Staging, Cisplatin, Pàncrees - Càncer - Tractament - Espanya, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], localizaciones geográficas::Europa (continente)::España [DENOMINACIONES GEOGRÁFICAS], Radiotherapy, business.industry, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Biliary Tract Neoplasms [DISEASES], medicine.disease, Therapeutics [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Gemcitabine, Treatment, Pancreatic Neoplasms, Spain, Concomitant, Quality of Life, Biliary tract cancer, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af373d2630e13536716a00764b1916fe
http://zaguan.unizar.es/record/102205

المؤلفون: Contreras-Toledo D; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Universidad de Oviedo, Oviedo, Spain. ct.debora@gmail.com., Jiménez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Universidad de Oviedo, Oviedo, Spain., López CL; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria (UNICAN), Santander, Spain., Montes AF; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., López Muñoz AM; Department of Medical Oncology, Hospital Universitario de Burgos, Burgos, Spain., Vázquez Rivera F; Department of Medical Oncology, Hospital Universitario de Santiago, Santiago de Compostela, Spain., Alonso V; Department of Medical Oncology, Hospital Universitario Miguel Servet, IISA, Zaragoza, Spain., Alcaide J; Department of Medical Oncology, Hospital Costa del Sol, Marbella, Medical Oncology Intercenter Unit, Hospital Universitario Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Salvà F; Department of Medical Oncology, Hospital Universitario Vall D'Hebrón, Vall D´Hebrón Institute of Oncology (VHIO), Barcelona, Spain., Covela Rúa M; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Guillot M; Department of Medical Oncology, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Martín Carnicero A; Department of Medical Oncology, Hospital San Pedro, Logroño, Spain., Jimeno Mate R; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Cameselle García S; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Asensio Martínez E; Department of Medical Oncology, Hospital General Universitario de Elche, Elche, Spain., González Astorga B; Department of Medical Oncology, Hospital Universitario Clínico San Cecilio, Granada, Spain., Fernandez-Diaz AB; Department of Medical Oncology, Hospital General de Valencia, Valencia, Spain., González Villaroel P; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Virgili Manrique AC; Department of Medical Oncology, Hospital Santa Creu i San Pau, Barcelona, Spain., Melián Sosa M; Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain., Alonso B; Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain., Cousillas Castiñeiras A; Department of Medical Oncology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Castañón López C; Department of Medical Oncology, Hospital Universitario de León, León, Spain., Aparicio J; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe de Valencia, Valencia, Spain., Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB, Murcia, Spain. alberto.carmonabayonas@gmail.com.

المصدر: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 777-787. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Colonic Neoplasms*/genetics, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation ; Disease Progression

المؤلفون: Valcarcel S; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Avenida Roma Sn., CP 33011, Oviedo, Spain. senavg@gmail.com., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., de Castro EM; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Orense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Calvo A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos Madrid, Madrid, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia, Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Macia-Rivas L; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Cerdà P; Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Navalon FG; Medical Oncology Department, Hospital Universitario Son Llatzer, Mallorca, Spain., Rambla MDM; Medical Oncology Department, Hospital Universitario Virgen de La Macarena, Seville, Spain., Richard MM; Medical Oncology Department, Catalan Institute of Oncology (ICO), L'Hospitalet, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, CP13/00126, PI17/0050 (ISCIII& FEDER), Murcia, Spain.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (7), pp. 4077-4089. Date of Electronic Publication: 2022 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Paclitaxel ; Antibodies, Monoclonal/therapeutic use ; Registries ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Ramucirumab

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Martinez DAS; Department of Medical Oncology, IMIB, Virgen de La Arrixaca University Hospital, Murcia, Región de Murcia, Spain., Quilez-Cutillas A; Department of Medical Oncology, Can Misses Hospital, Área de Salud de Ibiza y Formentera (ASEF), Ibiza, Illes Balears, Spain., Jimenez-Labaig P; Department of Medical Oncology, Cruces University Hospital, Barakaldo, Bizkaia, Spain., Sesma A; Department of Medical Oncology, Lozano Blesa University Clinical Hospital, Zaragossa, Aragón, Spain., Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Comunitat Valenciana, Spain.; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain., Pacheco-Barcia V; Department of Medical Oncology, Torrejón University Hospital, Madrid, Spain., Obispo B; Department of Medical Oncology, Infanta Leonor University Hospital, Madrid, Spain., Paez D; Department of Medical Oncology, Santa Creu i Sant Pau University Hospital, Barcelona, Catalunya, Spain., Quintanar T; Department of Medical Oncology, Elche University General Hospital, Elche, Comunitat Valenciana, Spain., Sanchez-Canovas M; Department of Hematology and Medical Oncology, Morales Meseguer University General Hospital, Murcia, Región de Murcia, Spain., Montes AF; Department of Medical Oncology, University Hospital Complex of Ourense (CHUO), Ourense, Galicia, Spain., Felip E; Vall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Vall d'Hebron University Hospital, Univesitat Autònoma de Barcelona (UAB), 119-129, 08035, Barcelona, Catalunya, Spain., Rodriguez-Lescure A; Department of Medical Oncology, Elche University General Hospital, Elche, Comunitat Valenciana, Spain., Elez E; Vall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Vall d'Hebron University Hospital, Univesitat Autònoma de Barcelona (UAB), 119-129, 08035, Barcelona, Catalunya, Spain. meelez@vhio.net.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Mar; Vol. 25 (3), pp. 796-802. Date of Electronic Publication: 2022 Nov 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Medical Oncology* , Oncologists*, Humans ; Female ; Male ; Spain ; Surveys and Questionnaires ; Employment

المؤلفون: Plazas JG; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. Electronic address: j.gallegoplazas@gmail.com., Arias-Martinez A; Pharmacy Department, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario de Ourense, Ourense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell, Spain., Pieras-Lopez A; Pharmacy Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - ISBAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia - Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.

المصدر: ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100514. Date of Electronic Publication: 2022 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Adenocarcinoma*/epidemiology , Adenocarcinoma*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/epidemiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Male ; Progression-Free Survival ; Registries

المؤلفون: Montes AF; Medical Oncology Department, Complexo Hospitalario Universitario, Ourense, Spain. afm1003@hotmail.com., Font EF; Medical Oncology Department, Hospital Universitario Vall D'Hebrón, Barcelona, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Apr; Vol. 24 (4), pp. 611-612. Date of Electronic Publication: 2022 Apr 01.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms* , Societies, Medical*, Humans

المؤلفون: Longo F; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, 28034, Spain., Jorge M; Hospital Álvaro Cunqueiro, Vigo (Pontevedra), 36213, Spain., Yaya R; Instituto Valenciano de Oncología (IVO), Valencia, 46009, Spain., Montes AF; Complexo Universitario Hospitalario de Ourense, 32005, Spain., Lago NM; Complejo Hospitalario Universitario, A Coruña, 15006, Spain., Brozos E; Complejo Hospitalario Universitario de Santiago, Santiago de Compostela (La Coruña), 15706, Spain., Aparicio J; Hospital Universitario y Politécnico La Fe, Valencia, 46026, Spain., Quintero G; Hospital Universitario Lucus Augusti, Lugo, 27003, Spain., Ceballos E; Hospital San Pedro de Alcántara, Cáceres, 10003, Spain., Buxó E; Hospital Quirón Salud, Barcelona, 08023, Spain., Lopez AM; Hospital Universitario de Burgos, 09006, Spain., Pellón ML; Complexo Universitario Hospitalario de El Ferrol (La Coruña), 15405, Spain., Molina R; Hospital Universitario Príncipe de Asturias, Alcalá de Henares (Madrid), 28805, Spain., Diaz-Paniagua L; Hospital Universitario de Getafe (Madrid), 28905, Spain., Cerdà P; Centro Médico Teknon, Barcelona, 08022, Spain., Leiva PL; Complejo Hospitalario de Jaén, 23007, Spain., Carnicero AM; Hospital de San Pedro, Logroño, 26006, Spain., Cousillas A; Complexo Universitario Hospitalario de Pontevedra, 36071, Spain., Paris L; Centro Oncológico de Galicia, La Coruña, 15009, Spain., García-Paredes B; Hospital Clínico San Carlos, Madrid, 28040, Spain., Romero C; Hospital POVISA, Vigo (Pontevedra), 36201, Spain., Ortega M; Department of Medical, Lilly, Madrid, 28108, Spain., Molero A; Department of Medical, Lilly, Madrid, 28108, Spain., la Torre S; Department of Medical, Lilly, Madrid, 28108, Spain., Jen MH; European Statistics Group, Lilly, Surrey, GU206PH, UK., Díaz-Cerezo S; Department of Medical, Lilly, Madrid, 28108, Spain.

المصدر: Future oncology (London, England) [Future Oncol] 2021 May; Vol. 17 (14), pp. 1777-1791. Date of Electronic Publication: 2021 Feb 16.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*therapy , Antibodies, Monoclonal, Humanized/*administration & dosage , Paclitaxel/*administration & dosage , Stomach Neoplasms/*therapy, Adenocarcinoma/diagnosis ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/statistics & numerical data ; Esophagogastric Junction/pathology ; Esophagogastric Junction/surgery ; Female ; Gastrectomy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoadjuvant Therapy/statistics & numerical data ; Paclitaxel/adverse effects ; Progression-Free Survival ; Retrospective Studies ; Spain/epidemiology ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Ramucirumab

المؤلفون: Gómez-España MA; Medical Oncology Department, Hospital Universitario Reina Sofía, IMIBIC, CIBERONC, Córdoba, Spain. magespanya@hotmail.com., Montes AF; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense (CHUO), Orense, Spain., Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario, UCM, CNIO, CIBERONC, 12 de Octubre, IIS imas12, Madrid, Spain., Mercadé TM; Medical Oncology Department, Hospital Universitari Vall D´Hebron, Barcelona, Spain., Maurel J; Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain., Martín AM; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Pazo-Cid R; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Vera R; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Carrato A; Medical Oncology Department, Hospital Universitario Ramón Y Cajal, Alcala University, IRYCIS, CIBERONC, Madrid, Spain., Feliu J; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC, IDIPAZ, Madrid, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 May; Vol. 23 (5), pp. 988-1000. Date of Electronic Publication: 2021 Mar 03.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biliary Tract Neoplasms/*therapy , Pancreatic Neoplasms/*therapy, Albumins/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biliary Tract Neoplasms/genetics ; Biliary Tract Neoplasms/pathology ; Biliary Tract Neoplasms/surgery ; Capecitabine/therapeutic use ; Chemoradiotherapy/methods ; Chemotherapy, Adjuvant/methods ; Cisplatin/therapeutic use ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Medical Oncology ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Oxaliplatin/therapeutic use ; Paclitaxel/therapeutic use ; Palliative Care ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery ; Quality of Life ; Societies, Medical ; Spain